Jazz Pharmaceuticals plc
- Stock
- Ticker JAZZ
- ISIN IE00B4Q5ZN47
- Nasdaq
- US listing in dollars
Performance, volatility and drawdowns of Jazz Pharmaceuticals plc since 11/2016, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.
Performance
$10,000 grew to $20,832. Global equities (VT): $29,042.
Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.
Declines from the peak
Lowest point −52.1% in 03/2020, measured from the peak in 06/2018. It took 36 months to get back to the old peak.
Financial statements
Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures
| Quarter end | 12/2024 | 03/2025 | 06/2025 | 09/2025 | 12/2025 | 03/2026 | 06/2026 | 09/2026 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | 1,088 | 898 | 1,046 | 1,126 | 1,198 | 1,069 | 1,208 | 1,243 |
| Operating income | 191 | -56 | -686 | 58 | 255 | 337 | 248 | -413 |
| EBITDA | 200 | -46 | -675 | 67 | 264 | 346 | 257 | -406 |
| Net income | 191 | -93 | -719 | 251 | 203 | 293 | 193 | -483 |
| Earnings per share | 3.02 | -1.52 | -11.74 | 4.08 | 3.34 | 4.43 | 2.78 | -7.48 |
| Balance sheet | ||||||||
| Total assets | 12,012 | 11,535 | 10,944 | 11,356 | 11,659 | 11,860 | 11,081 | 11,998 |
| Liabilities | 7,919 | 7,360 | 7,238 | 7,397 | 7,341 | 7,327 | 6,279 | 7,806 |
| Equity | 4,094 | 4,175 | 3,706 | 3,959 | 4,319 | 4,532 | 4,802 | 4,192 |
| Cash | 2,413 | 1,862 | 1,190 | 1,326 | 1,392 | 1,844 | 1,620 | 2,036 |
| Long-term debt | 6,078 | 5,336 | 4,336 | 4,332 | 4,328 | 4,324 | 3,335 | 4,552 |
| Cash flow | ||||||||
| Operating cash flow | 399 | 430 | 89 | 475 | 362 | 408 | 416 | 506 |
| Capital expenditure | -13 | -14 | -13 | -15 | -17 | -20 | -18 | -16 |
| Free cash flow | 385 | 416 | 76 | 460 | 346 | 389 | 398 | 490 |
Value it:DCF calculatorMultiples calculator
Annual returns
Best year 2025 at +38.0%, weakest 2021 at −22.8%. 6 of 9 full years were positive. * partial year.
Quarterly reports
Filing date with the SEC and earnings per share of the quarter
| Day | Earnings per share |
|---|---|
| 2 Nov 2026 | −$7.48 |
| 3 Aug 2026 | $2.78 |
| 5 May 2026 | $4.43 |
| 24 Feb 2026 | $3.34 |
| 5 Nov 2025 | $4.08 |
| 6 Aug 2025 | −$11.74 |
| 7 May 2025 | −$1.52 |
| 26 Feb 2025 | $3.02 |
| 7 Nov 2024 | $3.42 |
| 1 Aug 2024 | $2.49 |
| 2 May 2024 | −$0.23 |
| 28 Feb 2024 | $1.43 |
Key metrics
Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.
Valuation
- Market cap
- €13bn
- Market cap in trading currency
- $14.8bn
- Enterprise value
- $18.3bn
- P/E
- 75.0
- P/S
- 3.13
- P/B
- 3.53
- EV/Sales
- 3.88
- EV/EBITDA
- 39.8
- Earnings yield
- 1.3%
- FCF yield
- 11.0%
Results (last four quarters)
- Revenue
- $4.72bn
- Gross profit
- –
- EBITDA
- $461m
- Net income
- $206m
- Earnings per share
- $3.07
- Revenue per share
- $73.50
- Revenue growth
- +10.4%
- Earnings growth
- −292.3%
Profitability
- Gross margin
- –
- Operating margin
- 9.0%
- Net margin
- 4.4%
- Return on equity
- 5.1%
- Return on assets
- 1.7%
Balance sheet and cash flow
- Cash
- $2.04bn
- Cash per share
- $31.73
- Financial debt
- $5.57bn
- Debt/equity %
- 133
- Current ratio
- 1.82
- Book value per share
- $65.30
- Operating cash flow
- $1.69bn
- Free cash flow
- $1.62bn
Dividend
- Dividend yield
- 0.00%
- Dividend (12 months)
- $0.00
- Yield (12 months)
- 0.00%
- Payout ratio
- 0%
- Ex-dividend date
- –
Shares and trading
- Shares outstanding
- 64.2m
- Volume
- 984,644
- Avg. volume 3 months
- 885,095
- Relative volume
- 1.1
Price and technicals
- Price
- $230.26
- 1 day
- −2.6%
- 52-week high
- $261.62
- 52-week low
- $160.25
- Distance to 52-week high
- −12.0%
- Distance to 52-week low
- +43.7%
- Distance to 50-day line
- +0.7%
- Distance to 200-day line
- +3.8%
- RSI (14)
- 49
- Volatility 1M
- 46.0%
Performance
- 1 week
- −4.7%
- 1 month
- +7.3%
- 3 months
- −9.5%
- 6 months
- −4.0%
- YTD
- +35.4%
- 1 year
- +30.8%
Dates
- Fiscal year end
- 31 Dec 2025
- Most recent quarter
- 30 Sep 2026
Frequently asked questions
How has JAZZ performed since 11/2016?
$10,000 grew to $20,832 by 20 Nov 2026, which is +7.6% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.
How volatile is JAZZ?
Volatility was 29.0% per year, measured on monthly returns. The largest decline from a peak was −52.1%, with the low in 03/2020.
How does JAZZ compare with a broad equity ETF?
Over the same period Global equities (VT) returned +11.3% per year at 15.1% volatility, JAZZ returned +7.6% at 29.0%. The correlation of monthly returns was 0.33; 1 would mean they moved in lockstep.
Which currency are the figures in?
In US dollars, the currency of the US listing.
Why does this page show a US listing?
The figures use the stock's listing traded in the US. On individual days its path differs slightly from the price on the home exchange.